ADPT Adaptive Biotechnologies Inc.: Accounting Value per Share

Graphic logo of Adaptive Biotechnologies (ADPT)

The price action chart for Adaptive Biotechnologies (ADPT) illustrates the quotes of a company facing a liquidity deficit due to high research expenditures coupled with low profit levels, which constitutes 0.90. The business relies on government grants and test results. Development is proceeding through alliances with healthcare behemoths, where the implementation of AI for immunity analysis helps identify severe pathologies more rapidly.

Adaptive Biotech (ADPT): Share Book Value from 07/04/2022 to 10/26/2026

adaptivebiotech.com - analytical breakdowns and key metrics (ADPT)

- price and consensus price forecast:
Price Chart Adaptive Biotechnologies Corp|ADPT - Forecast Levels Chart
- market capitalization data:
Market Valuation Adaptive Biotechnologies Corporation|ADPT - Aggregate Business Value
- book capitalization data:
Net Assets per Single Share Adaptive Biotechnologies|ADPT - Net Asset Value|Market Capitalization to Book Value Ratio adaptivebiotech.com|ADPT - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Adaptive Biotechnologies|ADPT - Long-Term Debt to Capital|Short-Term Debt to Equity Adaptive Biotechnologies Corporation|ADPT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Adaptive Biotechnologies Corporation
Fundamental company valuation:Adaptive Biotechnologies Corp - ADPT
Manufactured products of Adaptive Biotechnologies Corporation

Institutional investors utilize this metric to determine the actual equity coverage of Adaptive Biotechnologies (ADPT) shares. The calculation is based on dividing net assets by the number of securities, eliminating distortions from goodwill revaluation. By analyzing the book value per common share, one can track the write-downs of illiquid positions. Optimized biosample logistics support the value of tangible assets. The stability of the chart confirms the fundamental reliability of the company's capital.

Competitors of Adaptive Biotechnologies (ADPT)

Net Assets per Single Share Argenx|BioNTech Pharma (BNTX) - Share Book Value|ABVX - Accounting Value per Share|ADMA (admabiologics.com) - Book Price of a Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share CLDX (Celldex Therapeutics)|auriniapharma.com - Book Value per Share|Net Assets per Single Share BioCryst Pharmaceuticals (BCRX)|VERA: Accounting Value of a Share|DNTH (Dianthus Pharma) - Net Assets per Single Share|Pharvaris Pharma (PHVS) - Accounting Value per Share|ABCL (AbCellera Biologics Inc) - Book Value per Share|Book Value per Share tourmalinebio.com (TRML)|Precigen (PGEN) - Accounting Value per Share|Accounting Value of a Share Pharming Group NV (PHAR)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|enGene Bio - Book Value per Share|RAPT - Book Value per Share|Book Value per Share aerovatetx.com|aclaristx.com (ACRS) - Equity per Share|KYTX (Kyverna Therapeutics, Inc.) - Book Value per Share|Book Value per Share TLSA|CABA - Net Assets per Single Share|Share Book Value Ventyx Biosciences, Inc VTYX|Accounting Value per Share Theratechnologies Inc. (THTX)|Book Price of a Share avalotx.com AVTX|Book Value per Share ELDN (Eledon Pharmaceuticals, Inc.)|Agenus, Inc. (AGEN) - Net Assets per Share|Climb Bio, Inc. (CLYM) - Accounting Value per Share|Zura Bio Ltd (ZURA) - Net Assets per Single Share|Book Value per Share ATYR (aTyr Pharma, Inc.)|Net Asset Value per Share Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Accounting Value per Share|Accounting Value of a Share shattucklabs.com (STTK)|Book Value per Share Equillium EQ|Net Assets per Single Share Connect Biopharma Holdings CNTB|Book Value per Share IMUX (Immunic Inc)|ATRA: Net Assets per Share|Net Assets per Single Share IFRX|Net Asset Value per Share X4 Pharmaceuticals Inc.|Adicet Bio Inc. (ACET) - Accounting Value per Share|Book Price of a Share Celularity Corp|INmune Bio, Inc. - Book Value per Share|Net Asset Value per Share barinthusbio.com (BRNS)|Kezar Life Sciences, Inc. - Book Value per Share|Accounting Value per Share SAB Biotherapeutics Inc. SABS|Book Value per Share Akari Therapeutics plc (AKTX)|ENLV: Accounting Value of a Share|Net Assets per Single Share q32bio.com|GOVX (geovax.com) - Equity per Share|Net Assets per Single Share EDSA (Edesa Biotech)|Net Asset Value per Share IBIO|Net Assets per Single Share Carisma Therapeutics (CARM)|Net Assets per Single Share XTLB (XTL Bio)|BOLT: Net Assets per Single Share|Net Asset Value per Share HCW Biologics, Inc. HCWB|Book Value per Share APVO|AIM - Book Value of One Share|aditxt.com - Book Value per Share|GRI Bio Corporation (GRI) - Net Assets per Share|Book Value per Share XRTX (XORTX Therapeutics Inc.)|Net Asset Value per Share HIND|REVB (Revelation Biosciences, Inc.) - Net Assets per Single Share|Net Assets per Share Indaptus Therapeutics Inc (INDP)|Book Value per Share SCNI (Scinai)|Book Value per Share CalciMedica Inc CALI|Affimed Therapeutics (AFMD) - Book Value per Share|ALLK: Equity per Share|Net Assets per Single Share hookipapharma.com (HOOK)|Share Book Value IGM Biosciences|iTeos (ITOS) - Accounting Value per Share|Book Price of a Share OCEA|TCBP - Net Assets per Single Share|Share Book Value thirdharmonicbio.com (THRD)